Novartis, AbbVie Score Win to Block West Virginia Drug Limit Law

The pharmaceutical industry notched a victory in its fight against a West Virginia law requiring it to distribute discounted drugs to an unlimited number of pharmacies under the federal 340B Drug Pricing Program.

Novartis AG, AbbVie Inc., and the Pharmaceutical Research and Manufacturers of America have shown that they will suffer irreparable harm in the absence of preliminary relief under West Virginia’s law (S.B. 325), Judge Thomas E. Johnston of the US District Court for the Southern District of West Virginia ordered Tuesday.

At issue before the court was whether S.B. 325 is preempted by federal ...